8-KEarnings & ResultsExhibits & Filings

ABBOTT LABORATORIES 8-K Report, Financial Results (Jul 18, 2007)

Filed July 18, 2007For Securities:ABT

Summary

Abbott Laboratories (ABT) filed an 8-K on July 18, 2007, to report its financial results for the second quarter of 2007. The filing primarily serves to furnish the press release announcing these results, which is incorporated by reference. Investors should note that Abbott utilized non-GAAP financial measures in its earnings announcement, which exclude certain specified items such as merger-related costs, purchase accounting adjustments, restructuring charges, and litigation expenses. Management believes these non-GAAP measures offer a clearer view of ongoing business performance by adjusting for unusual or unpredictable factors, allowing for a better evaluation of operational efficiency. While Abbott encourages investors to consider these non-GAAP figures for enhanced understanding, it strongly cautions that they should be viewed in conjunction with, and not as a replacement for, financial measures prepared in accordance with Generally Accepted Accounting Principles (GAAP).

Key Highlights

  • 1Filing reports Abbott Laboratories' second quarter 2007 financial results.
  • 2The primary purpose of the 8-K is to furnish the accompanying press release detailing the Q2 2007 earnings.
  • 3Abbott Laboratories employed non-GAAP financial measures in its earnings announcement.
  • 4Non-GAAP measures exclude items like merger-related costs, purchase accounting adjustments, and restructuring charges.
  • 5Management asserts that non-GAAP measures provide insight into ongoing business performance.
  • 6Investors are cautioned to consider non-GAAP measures alongside GAAP financial statements.
  • 7The press release (Exhibit 99.1) contains the detailed financial results and analysis.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report Abbott Laboratories' financial results for the second quarter of 2007 and to furnish the press release that contains these results, which is incorporated by reference.

Abbott Laboratories used both GAAP (Generally Accepted Accounting Principles) and non-GAAP financial measures in its Q2 2007 earnings announcement. The non-GAAP measures were presented to exclude specified items that management considers unusual or unpredictable.

Abbott Laboratories presents non-GAAP financial measures because management believes they provide useful information to investors by allowing for a better evaluation of ongoing business performance. These measures adjust for factors like merger costs, purchase accounting, and restructuring charges, which are not part of normal operations.

The company advises investors to consider these non-GAAP financial measures in addition to, and not as a substitute for, financial measures prepared in accordance with GAAP. This means investors should look at both the GAAP and non-GAAP figures to get a complete picture of the company's financial health.